•
Sep 30, 2023

ImmunityBio Q3 2023 Earnings Report

Total Revenue
$82K
Previous year: $118K
-30.5%
EPS
-$0.19
Previous year: -$0.22
-13.6%
R&D Expenses
$48.4M
SG&A Expenses
$31.8M
Gross Profit
-$4.5M
Previous year: -$5.86M
-23.1%
Cash and Equivalents
$190M
Previous year: $104M
+82.2%
Free Cash Flow
-$93.1M
Previous year: -$96.5M
-3.6%
Total Assets
$432M
Previous year: $353M
+22.5%

ImmunityBio

ImmunityBio